Background Hemolytic disease of the fetus and newborn is a public health problem caused by maternal-fetal incompatibility; no prophylaxis is available for most alloantibodies that induce this disease.

Objective To evaluate the knowledge of pregnant women and the clinical management of hemolytic disease of the fetus and newborn, as well as to describe the gestational profile, risk factors and ...

Considerable variations have been observed in the postnatal management and outcomes of hemolytic disease of the fetus and ...

Learn more about the potential benefits of delayed umbilical cord clamping, including increased blood flow and improved iron ...

Natera (NTRA), announced a new policy for commercial coverage of its cfDNA Fetal RhD noninvasive prenatal test, Fetal RhD NIPT from one of the ...

Homozygosity has been assumed for the sibling and the 2 cousins of the proposita, all of whom are now deceased and had hemolytic disease. Other studies. Addition of crystalline triosephosphate ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) and genetic testing, today announced a new policy for ...

The presence of abnormal hemoglobin (HbS, HbC, or HbE) may indicate sickle cell disease or anemia. 5 In addition to hemoglobin electrophoresis, other tests used to evaluate for a hemoglobinopathy ...

Periodontal disease is classically characterized by progressive destruction of the soft and hard tissues of the periodontal complex, mediated by an interplay between dysbiotic microbial communities ...

2,10,16 Other disease-modifying antirheumatic drugs (DMARDs) have been used in this setting, including cyclosporine A, leflunomide, azathioprine, hydroxychloroquine, D-penicillamine, and tacrolimus.

June 10, 2024 — Scientists have grown 'mini-guts' in the lab to help understand Crohn's disease, showing that 'switches' that modify DNA in gut cells play an ... Major Cause of Inflammatory ...

Jan. 27, 2025 — Heart disease remains the leading cause of death in the ... While Most Americans Use a Device to Monitor Their Heart, Few Share That Data With Their Doctor Jan. 22, 2025 — A ...